Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-03-25

Clinical Trial Update: Study to Find Out How Long it Takes Azelastine Hydrochloride 0.15% Nasal Spray to Relieve Symptoms in Patients Suffering From Allergic Rhinitis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating how long azelastine hydrochloride nasal spray takes to relieve symptoms in allergic rhinitis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Azelastine hydrochloride nasal spray 0.15% (azelastine hydrochloride)

Snippet

Sponsor: Bayer | Conditions: Allergic Rhinitis | Phase 3 | Status: COMPLETED